Asian equities rebounded overnight as yesterday’s AI bubble kerfuffle was short-lived.

On a reported basis, Diageo’s net sales dropped 2.2% between July and September, as trouble in North America and Asia Pacific endured.

In the spring, market commentators predicted a global bond sell-off. Six months later, the US Treasury market is still alive and well—here’s why.

Some of our favorite bond funds (yielding 8%+) just took a header. And it’s setting up the best buying opportunity we’ve seen in nearly three years for CEF investors.

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

Scott Bessent is arguably the biggest stock-market cheerleader in American political history. And that fact is throwing a floor under stocks in a way few people realize.